Evaluation of efficacy of vitamin e and N-Acetyl cysteine in gentamicin-induced nephrotoxicity in rats

Renal Failure

Volumn 33, Issue 3, 2011, Pages 341-347

  Patel Manali, Bhalchandra ^a   Deshpande, Shrikalp ^b   Shah, Gaurang ^b  

^a Shankersinh Vaghela Bapu Institute of Pharmacy   (India)

^b K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Gentamicin (GM); N acetyl cysteine (NAC)

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CREATININE; ENVION; G 0384608; GENTAMICIN; GLUCOSE; GLUTATHIONE; KD 283; MALONALDEHYDE; RANBIOTIC; SODIUM; UNCLASSIFIED DRUG; UREA; V 208804;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; LIPID PEROXIDATION; LYMPHOCYTIC INFILTRATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SODIUM EXCRETION; SODIUM URINE LEVEL; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; DRUG EVALUATION, PRECLINICAL; GENTAMICINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 79952669916     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.560987     Document Type: Article

References (29)

1. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the treatment and prevention of acute renal fail-ure. Adis Int Drugs. 2000;59(1):79-91. (Pubitemid 30150573)
2. Albright RC. Acute renal failure a practical update. Mayo Clin Proc. 2001;76:6-74.
3. Smith S, Marriott J. Acute renal failure. In: Walker R, Edwards C, eds. Acute Renal Failure: Pathophysiology, Diagno-sis, and Management. 3rd ed., Edinburgh: Churchill Living-stone; 2003:229-245.
4. Chattopadhyay B. Newborns and gentamicin-how much and how often? J Antimicrob Chemother. 2002;49:13-16. (Pubitemid 34100642)
5. Smith CR, Lipsky JJ, Laskin OL, et al. Double-blind compari-son of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980;302(20):1106-1109. (Pubitemid 10107526)
6. Tulkens PM. Experimental studies on nephrotoxicity of ami-noglycosides at low doses; mechanisms and perspectives. Am J Med. 1986;80:105-114. (Pubitemid 16036774)
7. Dominguez JH, Hale CC, Qulali M. Studies of renal injury. Gentamicin toxicity and expression of basolateral transporters. Am J Physiol. 1996;270:F245-F253.
8. Horio M, Fukuhara Y, Orita Y, et al. Gentamicin inhibits Na+ dependent D-glucose transport in rabbit kidney brush-border membrane vesicles. Biochem Biophys Acta. 1986;858:153-160.
9. Takamoto K, Kawada M, Usui T, Ishizuka M, Ikeda D. Inhibitory activity of dome formation in LLC PK1 cells is a selective index of aminoglycoside nephrotoxicity. J Antibiot (Tokyo). 2002;55(6):605-612.
10. Branch RA. Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389-2396.
11. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int. 1995;47:927-934.
12. Albright RC. Acute renal failure a practical update. Mayo Clin Proc. 2001;76:6-74.
13. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anesthesiol. 2004;18(1):37-52. (Pubitemid 38949985)
14. Humes DH, Weinberg JM, Knauss TC. Clinical and patho-physiologic aspects of aminoglycoside nephrotoxicity. Am J Kidney Dis. 1982;2:5-29. (Pubitemid 13232962)
15. Tulkens PM. Nephrotoxicity of aminoglycoside antibiotics. Toxicol Lett. 1989;46:107-23. (Pubitemid 19084006)
16. Coskun S, Ozge U, Nil UC, Sanem G, Selma B, Mujgan C. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharma Bull. 2007;30:79-83.
17. Meher SK, Chaudhuri SB, Marjit B, Munshi S. Nephropro-tective effect of nefroliv in gentamicin-induced nephrotoxicity. Phytomedica. 2001;2(1&2):41- 8.
18. Baliga R, Ueda N, Walker, PD, Shah SV. Oxidant mecha-nisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465-77. (Pubitemid 27106573)
19. Meister A. Glutathione metabolism and its selective modifica-tion. J Biol Chem. 1988; 263(33):17205-8. (Pubitemid 19029311)
20. Steiner R. Interpreting the fractional excretion of sodium. Am J Med. 1984;77(4):699-702. (Pubitemid 14047603)
21. Sandhya P, Mohandass S, Varalakshmi P. Role of dl-alpha lipoic acid in gentamicin induced nephrotoxicity. Mol Cell Biochem. 1995;145:11-17.
22. Tulkens PM. Experimental studies on nephrotoxicity of ami-noglycosides at low doses; mechanisms and perspectives. Am J Med. 1986;80:105-14. (Pubitemid 16036774)
23. Dominguez JH, Hale CC, Qulali M. Studies of renal injury. Gentamicin toxicity and expression of Basolateral transport-ers. Am J Physiol. 1996;270:F245-53.
24. Horio M, Fukuhara Y, Orita T, et al. Gentamicin inhibits Na+ dependent D-glucose transport in rabbit kidney brush-border membrane vesicles. Bio Chem Biophys Acta. 1986;858:153-60.
25. Takamoto K, Kawada M, Usui T, Ishizuka M, Ikeda D. Inhibitory activity of dome formation in LLC PK1 cells is a selective index of aminoglycoside nephrotoxicity. J Antibiot (Tokyo) 2002;55(6):605-12.
26. Branch RA. Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389-96.
27. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995;47:927-34.
28. Albright RC. Acute renal failure a practical update. Mayo Clin Proc 2001;76:6-74.
29. Evenepoel P. Acute Toxic Renal Failure. Best Pract Res Clin Anesthesiol 2004;18(1):37-52. (Pubitemid 38949985)